Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 86426-17-7
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram
Supply Ability: G,KG,TON
Appearance:: |
White To Off-white Powder |
CAS NO:: |
86426-17-7 |
Molecular Formula:: |
C6H18N2O4 |
Molecular Weight:: |
182.21800 |
EINECS NO:: |
695-494-3 |
MDL NO:: |
MFCD13461779 |
Appearance:: |
White To Off-white Powder |
CAS NO:: |
86426-17-7 |
Molecular Formula:: |
C6H18N2O4 |
Molecular Weight:: |
182.21800 |
EINECS NO:: |
695-494-3 |
MDL NO:: |
MFCD13461779 |
Product Description:
Product Name: Mildronate dehydrate CAS NO: 86426-17-7
Synonyms:
3-(2,2,2-Trimethylhydrazinium)propionate dihydrate;
Hydrazinium, 2-(2-carboxyethyl)-1,1,1-trimethyl-, inner salt;
Meldonium;
Chemical & Physical Properties:
Appearance: White to off-white powder
Assay :≥99.00%
Storage Temp.: 2-8℃
Solubility: H2O: >40mg/mL
Safety Information:
Hazard Code: Xi
Risk Statements: R36/37/38
Safety Statement: S26
WGK Germany: 3
Symbol: GHS07
Signal Word: Warning
Hazard Statements: H315-H319-H335
Precautionary Statements: P261-P305 + P351 + P338
At present, the commonly used drugs for the prevention and treatment of myocardial ischemia in clinic mainly include nitrate esters, β-blockers, calcium channel blockers and Chinese herbal medicine. Their mechanism of action is to increase the blood supply to the myocardium. Reduce oxygen consumption; Protect ischemic cardiomyocytes from damage to serosal membrane mitochondria and nuclear membrane; Improve myocardial metabolism, increase the supply of nutrient substrates and penetrate into ischemic areas. In recent years, the role of drugs to improve myocardial metabolism in preventing myocardial ischemia-reperfusion Chemicalbook injury has attracted much attention from many scholars. Myocardial metabilityameliorants are drugs that increase myocardial tolerance to ischemia and/or reperfusion injury by improving myocardial metabolism at the myocyte level. Therefore, it has obvious myocardial protective effect, and has no obvious effect on hemodynamic parameters, cardiac blood supply and cardiac oxygen consumption have no significant changes. These drugs are also known as cellular antiischemia agents because of their distinct differences with other antiischemia agents.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.